Buscar resultados de ensayos clínicos
Leukemia, Myelomonocytic, Juvenile - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) Condición: Juvenile Myelomonocytic Leukemia Fecha: 2005-09-09 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Condición: Juvenile Myelomonocytic Leukemia Fecha: 2013-04-02 Intervenciones:
|
Completed |
Nombre del estudio: Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia Condición: Juvenile Myelomonocytic Leukemia Fecha: 2001-10-11 Intervenciones:
|
Recruiting |
Nombre del estudio: Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) Condición:
Intervenciones: Drug: Azacitidine Other Name: Vidaza |
Terminated |
Nombre del estudio: Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation Condición: Leukemia Fecha: 2008-02-06 Intervenciones:
|
Terminated |
Nombre del estudio: Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia Condición: Leukemia Fecha: 2007-07-27 Intervenciones: Drug: Etanercept 0.8 mg/kg Subcutaneously Once A Week for 90 Days |
Active, not recruiting |
Nombre del estudio: Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia Condición:
|
Terminated |
Nombre del estudio: Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood Condición:
Fecha: 2008-04-17 |
Not yet recruiting |
Nombre del estudio: Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) Condición:
|